Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose
Aurelia H.M. de Vries Schultink*, Robert P. Doornbos, Alexander B.H. Bakker, Kees Bol, Mark Throsby, Cecile Geuijen, David Maussang, Jan H.M. Schellens, Jos H. Beijnen, Alwin D.R. Huitema
Research output: Contribution to journal › Article › Academic › peer-review
Fingerprint
Dive into the research topics of 'Translational PK-PD modeling analysis of MCLA-128, a HER2/HER3 bispecific monoclonal antibody, to predict clinical efficacious exposure and dose'. Together they form a unique fingerprint.